Adopting NGS for tumor profiling: Accessible sequencing. Flexible solutions.

Adopting NGS for tumor profiling: Accessible sequencing. Flexible solutions.

Maude Champagne, Commercial Development Manager, Oncology, Illumina
Topic: Sequencing : Cancer Genomics

Next-generation sequencing (NGS) can help you avoid costly and time-consuming iterative testing while simultaneously helping to preserve precious samples. In this webinar, you will learn more about the advantages that NGS offers over traditional methods, and be introduced to the newest, cost effective solution for hematological and solid tumor profiling.



Introducing Nextera™ Flex for Enrichment
Grace DeSantis, Ph.D. Director, Product Development, Illumina, Inc.
Topic: Cancer Genomics : Human Genetics & Genetic Disease
IASLC 2019 Targeted Therapies of Lung Cancer Meeting
Santa Monica, CA | North America
Topic: Cancer Genomics
Advances in Genome Biology and Technology (AGBT) Annual Meeting 2019
Marco Island, FL | North America
Topic: Agriculture Genomics : Cancer Genomics : Forensic Genomics : Reproductive & Genetic Health : Human Genetics & Genetic Disease : Microbiology & Infectious Disease : HLA Typing